When setting personalized HbA1c targets, careful consideration should be given to several factors, including the duration of diabetes, the patient's life expectancy, the use of insulin and secretagogues, history of severe hypoglycemia, and the presence of other conditions (such as multiple comorbidities, cognitive impairment, polypharmacy).216. The gene discussed is INS; the disease is Hypoglycemia.